Price (90d)
$5.69Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $3.24B | $-70.79M | $-0.52 |
| 2024 | $3.26B | $90.42M | $0.62 |
| 2023 | $3.20B | $-678.89M | $-5.32 |
| 2022 | $2.97B | $69.32M | $0.52 |
| 2021 | $2.45B | $156.18M | $1.12 |
Social Signal Score
Earnings
Tue, Nov 3(in 3 months)
Consensus estimate $-0.03 per share
Typical surprise -20.6% (median, so one quarter with a near-zero estimate can't distort it)
- Tue, Aug 4$0.06 vs $0.17miss
- Tue, May 5$-0.06 vs $0.01miss
- Tue, Feb 24$0.27 vs $0.34miss
- Tue, Nov 4$0.22 vs $0.24miss
- Tue, Aug 5$0.01 vs $0.15miss
- Tue, May 6$0.01 vs $0.01beat
Estimates and results for AHCO via Financial Modeling Prep. Beating consensus says the company cleared the bar analysts set, not that the business grew.
Valuation
AHCOhas no positive reported earnings per share, so an earnings-multiple projection can't be built for it. Companies are valued on other measures at this stage — revenue growth, cash burn, or book value — none of which this calculator models.
Mentions (5)
- Newsglobenewswire.com·19h ago·Neutral
AdaptHealth Corp. Data Breach: Edelson Lechtzin LLP Launches Investigation Into Exposure of Personal Information CONSHOHOCKEN, Pa., Aug. 14, 2026 (GLOBE NEWSWIRE) -- Edelson Lechtzin LLP, a national class action law firm, is investigating data privacy claims arising from the AdaptHealth Corp. (Nasdaq: AHCO) data breach.
View source ↗ - Newsprnewswire.com·3d ago·Neutral
AdaptHealth Corp. (AHCO) Securities Investigation Notice - Levi & Korsinsky AdaptHealth Corp. reported second quarter 2026 revenue of $740.3 million against consensus of roughly $847 million to $849 million, and a GAAP loss of $0.99 per share against expectations of approximately $0.15. Shares fell as much as 26%.
View source ↗ - Newsmarketbeat.com·4d ago·Negative
AdaptHealth Sells Diabetes Unit to Sharpen Focus on Sleep, Respiratory Growth AdaptHealth NASDAQ: AHCO executives outlined the company's second-quarter performance, portfolio changes and plans to focus capital on sleep, respiratory and home medical equipment businesses during a Canaccord conference discussion.
View source ↗ - Newsfool.com·6d ago·Negative
Why AdaptHealth Stock Plummeted This Week AdaptHealth posted a huge earnings miss in Q2, and sales also came in below expectations. The company also lowered its fiscal performance targets for the year.
View source ↗ - Newsbusinesswire.com·6d ago·Negative
AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law LOS ANGELES--(BUSINESS WIRE)---- $AHCO--AHCO Investors Have Opportunity to Join AdaptHealth Corp. Fraud Investigation with SBS Law.
View source ↗